Top Markets
#1 Rain Rain +17.54%
#2 Axie Infinity Axie Infinity +16.67%
#3 Collect on Fanable Collect on Fanable +16.14%
#4 Pharos Pharos +15.32%
#5 Aethir Aethir +14.52%
#6 Beam Beam +13.26%
#7 Ore Ore +13.10%
#8 Basic Attention Basic Attention +11.92%
#9 Phala Phala +11.70%
#10 Espresso Espresso +9.55%
Coin of the day
Rain Rain
Settings
Language
ENGLISH
Currency
USD
Theme
CYduct Diagnostics, Inc. CYduct Diagnostics, Inc.

CYduct Diagnostics, Inc.

CYDX
Rank in Stocks #36385
CYduct Diagnostics, Inc. operates as a medical instrument enterprise that... CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses. The company's extensive product offerings include specialized breast endoscopy systems, an assortment of camera solutions (such as 3-chip and 1-chip models), and all necessary accessories. They also provide a broad selection of endoscopic instruments, encompassing surgical tools like dissectors, graspers, scissors, needle holders, fan retractors, cautery devices, and insufflation needles. Furthermore, CYduct supplies illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps, alongside insufflators. For surgical specialties, their portfolio features laparoscopic instruments designed for general surgery, lymphadenectomy, gynecology, and thorascopy. Complementing these are rigid scopes (like laparoscopes, operative scopes, and cystoscopes) with their corresponding accessories, as well as trocar and cannula sets, video carts, and both insulated and non-insulated instrument handles. Uniquely, the company also provides instrumentation tailored for veterinary applications. Established in 1986, CYduct Diagnostics, Inc. is headquartered in Westport, Connecticut. The firm was formerly known as Solos Endoscopy, Inc., before adopting its current name in December 2020.
Share Price
$0.5
Last synced: 2026-10-01
Market Cap
$2.62M
Change (1 day)
0.00%
Change (1 year)
85.19%
Country
US
Trade CYduct Diagnostics, Inc. (CYDX)

Category

Healthcare
P/E ratio for CYduct Diagnostics, Inc. (CYDX)
P/E ratio as of 2026 TTM: 0
According to CYduct Diagnostics, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for CYduct Diagnostics, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 31.78 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 28.32 -
US
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 17.60 -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.